NVS
Novartis AG ADR
NYSE: NVS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$147.85
+3.44% today
Updated 2026-04-30
Market cap
$280.79B
P/E ratio
20.32
P/S ratio
4.96x
EPS (TTM)
$7.16
Dividend yield
3.26%
52W range
$102 – $165
Volume
2.1M
Novartis AG ADR (NVS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35.10B | $38.95B | $42.58B | $45.10B | $51.56B | $59.38B | $51.97B | $52.72B | $53.63B | $50.39B | $49.44B | $43.40B | $46.10B | $48.68B | $49.90B | $43.97B | $43.46B | $46.66B | $51.72B | $54.81B |
| Revenue growth (YoY) | — | +10.9% | +9.3% | +5.9% | +14.3% | +15.2% | -12.5% | +1.4% | +1.7% | -6.1% | -1.9% | -12.2% | +6.2% | +5.6% | +2.5% | -11.9% | -1.2% | +7.4% | +10.8% | +6.0% |
| Cost of revenue | $9.41B | $11.03B | $11.44B | $12.18B | $14.49B | $18.98B | $15.87B | $16.58B | $17.34B | $17.40B | $17.52B | $13.63B | $14.51B | $14.43B | $15.12B | $11.73B | $11.58B | $12.47B | $12.83B | $13.69B |
| Gross profit | $25.69B | $27.91B | $31.14B | $32.92B | $37.07B | $40.39B | $36.10B | $36.14B | $36.29B | $32.98B | $31.92B | $29.77B | $31.59B | $34.25B | $34.78B | $32.24B | $31.88B | $34.19B | $38.90B | $41.12B |
| Gross margin | 73.2% | 71.7% | 73.1% | 73.0% | 71.9% | 68.0% | 69.5% | 68.6% | 67.7% | 65.5% | 64.6% | 68.6% | 68.5% | 70.4% | 69.7% | 73.3% | 73.4% | 73.3% | 75.2% | 75.0% |
| R&D | $5.32B | $6.43B | $7.22B | $7.47B | $9.07B | $9.58B | $8.59B | $9.07B | $9.09B | $8.94B | $9.04B | $8.39B | $8.49B | $9.40B | $8.98B | $8.64B | $9.17B | $11.37B | $10.02B | $10.74B |
| SG&A | $1.88B | $2.13B | $2.25B | $2.28B | $2.48B | $2.97B | $2.53B | $2.60B | $2.62B | $2.48B | $2.19B | $2.14B | $16.47B | $14.37B | $14.20B | $14.81B | $14.25B | $14.32B | $12.57B | $13.24B |
| Operating income | $7.64B | $6.78B | $8.96B | $9.98B | $11.53B | $10.78B | $11.51B | $10.98B | $11.09B | $8.98B | $8.27B | $8.70B | $8.40B | $9.09B | $10.15B | $10.06B | $7.95B | $9.77B | $14.54B | $17.07B |
| Operating margin | 21.8% | 17.4% | 21.1% | 22.1% | 22.4% | 18.2% | 22.1% | 20.8% | 20.7% | 17.8% | 16.7% | 20.0% | 18.2% | 18.7% | 20.3% | 22.9% | 18.3% | 20.9% | 28.1% | 31.2% |
| EBITDA | $10.18B | $10.58B | $12.46B | $12.77B | $15.81B | $17.09B | $16.40B | $15.89B | $17.66B | $14.26B | $14.57B | $14.59B | $20.24B | $15.62B | $17.21B | $30.91B | $14.68B | $18.25B | $20.71B | $22.99B |
| EBITDA margin | 29.0% | 27.2% | 29.3% | 28.3% | 30.7% | 28.8% | 31.6% | 30.2% | 32.9% | 28.3% | 29.5% | 33.6% | 43.9% | 32.1% | 34.5% | 70.3% | 33.8% | 39.1% | 40.1% | 41.9% |
| EBIT | $8.26B | $7.72B | $9.79B | $10.47B | $12.39B | $11.31B | $11.96B | $11.49B | $12.98B | $8.79B | $8.52B | $9.85B | $15.03B | $9.79B | $10.75B | $25.32B | $7.98B | $9.98B | $14.65B | $17.63B |
| Interest expense | $266.00M | $237.00M | $249.00M | $440.29M | $610.05M | $691.74M | $655.00M | $664.00M | $701.00M | $691.47M | $729.00M | $802.00M | $973.22M | $902.93M | $921.00M | $905.00M | $834.62M | $876.12M | $1.04B | $1.19B |
| Income tax | $1.17B | $947.00M | $1.34B | $1.47B | $1.73B | $1.48B | $1.71B | $1.50B | $1.54B | $1.11B | $1.12B | $1.60B | $1.29B | $1.79B | $1.81B | $1.63B | $1.13B | $551.00M | $1.70B | $2.40B |
| Effective tax rate | 14.0% | 7.3% | 14.0% | 14.9% | 15.0% | 14.2% | 15.5% | 14.0% | 13.1% | 5.9% | 14.3% | 17.2% | 9.3% | 13.3% | 18.3% | 6.3% | 14.0% | 3.6% | 12.5% | 14.6% |
| Net income | $7.17B | $11.95B | $8.20B | $8.40B | $9.79B | $8.94B | $9.27B | $9.18B | $10.21B | $17.78B | $6.71B | $7.70B | $12.61B | $11.73B | $8.07B | $24.02B | $6.96B | $14.85B | $11.94B | $14.06B |
| Net income growth (YoY) | — | +66.5% | -31.4% | +2.5% | +16.6% | -8.7% | +3.7% | -1.0% | +11.3% | +74.2% | -62.3% | +14.8% | +63.7% | -7.0% | -31.2% | +197.6% | -71.0% | +113.5% | -19.6% | +17.7% |
| Profit margin | 20.4% | 30.7% | 19.2% | 18.6% | 19.0% | 15.1% | 17.8% | 17.4% | 19.0% | 35.3% | 13.6% | 17.7% | 27.4% | 24.1% | 16.2% | 54.6% | 16.0% | 31.8% | 23.1% | 25.6% |